{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:40:59Z","timestamp":1791405659581,"version":"4.3.3"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":3025,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science, and Technology","doi-asserted-by":"crossref","award":["21390256"],"award-info":[{"award-number":["21390256"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science, and Technology","doi-asserted-by":"crossref","award":["17016051"],"award-info":[{"award-number":["17016051"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science, and Technology","doi-asserted-by":"crossref","award":["22112010A01"],"award-info":[{"award-number":["22112010A01"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009954","name":"Taiho Pharmaceutical Company","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009954","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009954","name":"Taiho Pharmaceutical Company","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009954","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.ajpath.2011.05.060","type":"journal-article","created":{"date-parts":[[2011,7,23]],"date-time":"2011-07-23T09:23:04Z","timestamp":1311412984000},"page":"1483-1493","source":"Crossref","is-referenced-by-count":53,"title":["Pleural Mesothelioma Instigates Tumor-Associated Fibroblasts To Promote Progression via a Malignant Cytokine Network"],"prefix":"10.1016","volume":"179","author":[{"given":"Qi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadaaki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimi","family":"Bando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisanori","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saburo","family":"Sone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Iwakiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Itoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhiro","family":"Utsugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Yasumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2011.05.060_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/sonc.2002.30227","article-title":"The pathogenesis of mesothelioma","volume":"29","author":"Carbone","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ajpath.2011.05.060_bib2","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2011.05.060_bib3","doi-asserted-by":"crossref","first-page":"332S","DOI":"10.1378\/chest.107.6_Supplement.332S","article-title":"Current approach to malignant mesothelioma of the pleura","volume":"107","author":"Aisner","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.ajpath.2011.05.060_bib4","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2011.05.060_bib5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature03096","article-title":"Stromal fibroblasts in cancer initiation and progression","volume":"432","author":"Bhowmick","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2011.05.060_bib6","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.cell.2008.04.045","article-title":"Systemic endocrine instigation of indolent tumor growth requires osteopontin","volume":"133","author":"McAllister","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2011.05.060_bib7","doi-asserted-by":"crossref","first-page":"6630","DOI":"10.1158\/1078-0432.CCR-09-1001","article-title":"Crosstalk to stromal fibroblasts induces resistance of lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors","volume":"15","author":"Wang","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2011.05.060_bib8","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1200\/JCO.2007.14.9930","article-title":"Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study","volume":"26","author":"Saltz","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2011.05.060_bib9","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","article-title":"Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer","volume":"355","author":"Sandler","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2011.05.060_bib10","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1200\/JCO.2009.26.7351","article-title":"Pemetrexed plus bevacizumab for second-line therapy of non-small-cell lung cancer: the importance of patient selection","volume":"28","author":"Araujo","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2011.05.060_bib11","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1200\/JCO.2003.04.105","article-title":"Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial\u2014the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group","volume":"21","author":"Rosen","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajpath.2011.05.060_bib12","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1158\/1078-0432.CCR-07-0501","article-title":"The therapeutic efficacy of anti vascular endothelial growth factor antibody, bevacizumab, and pemetrexed against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice","volume":"13","author":"Li","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2011.05.060_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/08820130600754960","article-title":"More than structural cells, fibroblasts create and orchestrate the tumor microenvironment","volume":"35","author":"Baglole","year":"2006","journal-title":"Immunol Invest"},{"key":"10.1016\/j.ajpath.2011.05.060_bib14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/(SICI)1096-9896(199612)180:4<389::AID-PATH685>3.0.CO;2-K","article-title":"Immunoreactivity for hepatocyte growth factor\/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas","volume":"180","author":"Harvey","year":"1996","journal-title":"J Pathol"},{"key":"10.1016\/j.ajpath.2011.05.060_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s00401-003-0708-z","article-title":"Expression of hepatocyte growth factor and c-Met in the anterior horn cells of the spinal cord in the patients with amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS and familial ALS with superoxide dismutase 1 gene mutation","volume":"106","author":"Kato","year":"2003","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2011.05.060_bib16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2174\/1871520611009010036","article-title":"Anti-cancer approach with NK4: bivalent action and mechanisms","volume":"10","author":"Nakamura","year":"2010","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.ajpath.2011.05.060_bib17","first-page":"3239","article-title":"A rapid in vitro assay for quantitating the invasive potential of tumor cells","volume":"47","author":"Albini","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2011.05.060_bib18","doi-asserted-by":"crossref","first-page":"9479","DOI":"10.1158\/0008-5472.CAN-08-1643","article-title":"Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations","volume":"68","author":"Yano","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2011.05.060_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1349-7006.2006.00163.x","article-title":"Novel orthotopic implantation model of human malignant pleural mesothelioma (EHMES-10 cells) highly expressing vascular endothelial growth factor and its receptor","volume":"97","author":"Nakataki","year":"2006","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ajpath.2011.05.060_bib20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1158\/1078-0432.CCR-09-1204","article-title":"Hepatocyte growth factor reduces susceptibility to an irreversible epidermal growth factor receptor inhibitor in EGFR-T790M mutant lung cancer","volume":"16","author":"Yamada","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2011.05.060_bib21","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/342440a0","article-title":"Molecular cloning and expression of human hepatocyte growth factor","volume":"342","author":"Nakamura","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2011.05.060_bib22","first-page":"1093","article-title":"Basic fibroblast growth factor in mesothelioma pleural effusions: correlation with patient survival and angiogenesis","volume":"18","author":"Strizzi","year":"2001","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ajpath.2011.05.060_bib23","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1158\/1078-0432.CCR-07-1388","article-title":"Imatinib mesylate enhances therapeutic effects of gemcitabine in human malignant mesothelioma xenografts","volume":"14","author":"Bertino","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2011.05.060_bib24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/bjc.1996.64","article-title":"Hepatocyte growth factor\/scatter factor is present in most pleural effusion fluids from cancer patients","volume":"73","author":"Eagles","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajpath.2011.05.060_bib25","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/bjc.1998.176","article-title":"Expression of HGF\/SF in mesothelioma cell lines and its effects on cell motility, proliferation and morphology","volume":"77","author":"Harvey","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajpath.2011.05.060_bib26","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1158\/0008-5472.CAN-05-3329","article-title":"Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor\/c-Met-dependent human tumors","volume":"66","author":"Burgess","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2011.05.060_bib27","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.ejca.2010.02.036","article-title":"Interaction between human-breast cancer metastasis and bone microenvironment through activated hepatocyte growth factor\/Met and beta-catenin\/Wnt pathways","volume":"46","author":"Previdi","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajpath.2011.05.060_bib28","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1002\/ijc.25197","article-title":"Inhibition of Met\/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma","volume":"127","author":"Suzuki","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2011.05.060_bib29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00280-006-0243-4","article-title":"Negative results of an Italian Group for Mesothelioma (G.I.Me.) pilot study of single-agent imatinib mesylate in malignant pleural mesothelioma","volume":"59","author":"Porta","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ajpath.2011.05.060_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.lungcan.2005.04.010","article-title":"Limited efficacy of imatinib mesylate in malignant mesothelioma: a phase II trial","volume":"50","author":"Mathy","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ajpath.2011.05.060_bib31","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/S0002-9440(10)64828-6","article-title":"Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor\/vascular permeability factor by human lung cancer cells","volume":"157","author":"Yano","year":"2000","journal-title":"Am J Pathol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944011005608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944011005608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T06:46:12Z","timestamp":1576219572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944011005608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0002944011005608"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2011.05.060","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}